On 5 May 2021 the teams of the John Walton Muscular Dystrophy Research Centre, the NIHR Newcastle Clinical Research Facility and the Great North Children’s Hospital dosed the first patient with Duchenne muscular dystrophy in the UK in the CIFFREO gene therapy trial. The trial, sponsored by Pfizer, opened to recruitment on 03 March 2021 and is an NIHR portfolio study. Read more here